↓ Skip to main content

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

Overview of attention for article published in Trials, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news
1 news outlet
twitter
15 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care
Published in
Trials, July 2022
DOI 10.1186/s13063-022-06492-6
Pubmed ID
Authors

Sarah L. Alderson, Alexandra Wright-Hughes, Alexander C. Ford, Amanda Farrin, Suzanne Hartley, Catherine Fernandez, Christopher Taylor, Pei Loo Ow, Emma Teasdale, Daniel Howdon, Elspeth Guthrie, Robbie Foy, Matthew J. Ridd, Felicity L. Bishop, Delia Muir, Matthew Chaddock, Amy Herbert, Deborah Cooper, Ruth Gibbins, Sonia Newman, Heather Cook, Roberta Longo, Hazel Everitt

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 10%
Researcher 3 8%
Student > Bachelor 3 8%
Student > Doctoral Student 2 5%
Lecturer 2 5%
Other 7 18%
Unknown 18 46%
Readers by discipline Count As %
Medicine and Dentistry 6 15%
Psychology 3 8%
Social Sciences 3 8%
Business, Management and Accounting 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 5 13%
Unknown 18 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2023.
All research outputs
#2,023,895
of 25,988,468 outputs
Outputs from Trials
#473
of 1,868 outputs
Outputs of similar age
#43,872
of 441,472 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 25,988,468 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,868 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,472 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them